Dual-optic accommodating IOL earns European CE Mark

January 1, 2006

Europe's CE Mark was given to the dual-optic accommodating IOL (Synchrony, Visiogen Inc.) for cataract and refractive surgery. The new designation will allow the company to "expand into post-marketing research studies within Europe to build the scientific foundation further for Synchrony," said Reza Zadno, PhD, Visiogen president and chief executive officer.

Europe's CE Mark was given to the dual-optic accommodating IOL (Synchrony, Visiogen Inc.) for cataract and refractive surgery. The new designation will allow the company to "expand into post-marketing research studies within Europe to build the scientific foundation further for Synchrony," said Reza Zadno, PhD, Visiogen president and chief executive officer.

The system, including a dual-optic lens and pre-loaded injector, is self-contained and does not require lens handling. The lens can be inserted through a 3.6- to 3.8-mm clear-corneal incision. The single-piece silicone lens unfolds in the eye upon insertion and features two optics connected by a spring system. The springs connect a 5.5-mm high-power anterior optic and a 6-mm negative power posterior optic. The spring action moves the front optic and changes the focus from near to far. The positive- and negative-powered optics are customized for each patient.

The FDA is currently conducting a clinical study on this lens.